Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease

Diabetic Medicine

Volumn 20, Issue 10, 2003, Pages 832-837

  Al Daghri, Nasser ^a   Al Rubean, K ^b   Bartlett, W A ^a   Al Attas, O ^c   Jones, A F ^a   Kumar, S ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Coronary heart disease; Diabetes mellitus; Leptin; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN; GLUCOSE; INSULIN; LEPTIN; LIPID; TRIACYLGLYCEROL; APOLIPOPROTEIN A1; CHOLESTEROL;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SAUDI ARABIA; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DIASTOLE; MALE; MIDDLE AGED; STATISTICAL MODEL;

ADULT; APOLIPOPROTEIN A-I; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIASTOLE; HUMANS; INSULIN; LEPTIN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SAUDI ARABIA; TRIGLYCERIDES;

EID: 0642373591     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01044.x     Document Type: Article

References (49)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J et al. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 1996; 313: 965-969.
3. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995; 1: 950-953.
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
6. Meigs JBDAR, Wilson PW, Cuples LA, Nathan DM, Singer DE. Risk variable clustering in insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594-600.
7. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
8. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356-361.
9. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
10. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991.
11. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
12. McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, Leonnetti DL et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999; 22: 65-70.
13. Malmstrom R, Taskinen MR, Karonen SL, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
14. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
15. Yarnell JW, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J 1994; 71: 293-296.
16. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor. Diabetes Care 1995; 18:1299-1304.
17. Sheu WH, Lee WJ, Chen YT. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289-1295.
18. Passaro A, Calzoni F, Zamboni PF, Manservigi D, Alberti L, Dalla Nora E et al. Role of diabetes in influencing leptin concentration in elderly overweight patients. Eur J Endocrinol 2001; 145: 173-179.
19. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism: Clin Exp 2001; 50: 1197-1202.
20. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928-933.
21. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052-3056.
22. Alballa SR, Bamgboye EA, al-Sekeit M, Alballaa SR. Causes of morbidity among a sample of elderly hospital patients in Riyadh, Saudi Arabia. J Trop Med Hygiene 1993; 96: 157-162.
23. R ASBEa-SMAR. Pattern of adult admission into medical wards of King Khalid uinversity Hospital. Saudi Med J 1993; 13: 8-13.
24. Al-Nuaim AR. Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia. Diabetic Med 1997; 14: 595-602.
25. Al-nozah M, Al-Mazrou Y, Al-Matoug M, Arafah M, Nouh M, Al-Harti M et al. Coronary Artery Disease in Saudi Arabia: a National Study. J Saudi Heart A 2000; 12: 44-45.
26. Al-Nuaim AA, Bamgboye EA, al-Rubeaan KA, al-Mazrou Y. Overweight and obesity in Saudi Arabian adult population, role of socio-demographic variables. J Community Health 1997; 22: 211-223.
27. Alobaid AGR, Bointon B. Coronary Heart Disease mortality in the Eastern province of Saudi Arabia in 1989 and 1990. Ann Saudi Med 1994; 14: 387-391.
28. Al-Shammari SA, Ali M, Al-Shammari A, Al-Maatouq M, Tennier A, Armstrong K. Blood lipid concentrations and other cardiovascular risk factors among Saudis. Fam Pract 1994; 11: 153-158.
29. Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002; 162: 273-279.
30. Alberti K. Zimmet PZ for the WHO consultation definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998; 15: 539-553.
31. Matthews DRHJ, Rudenski AS, Naylor BA, Treacher DF, Turner RL. Homeostasis model assessment, insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
32. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14: 200-208.
33. Haffner SM, Mykkanen L, Rainwater DL, Karhapaa P, Laakso M. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? Obes Res 1999; 7: 164-169.
34. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J et al. Leptin and other components of the Metabolic Syndrome in Mauritius-a factor analysis. Int J Obes Relat Metab Disord 2001; 25: 126-131.
35. Misra A, Arora N, Mondal S, Pandey RM, Jailkhani B, Peshin S et al. Relation between plasma leptin and anthropometric and metabolic covariates in lean and obese diabetic and hyperlipidaemic Asian Northern Indian subjects. Diabetes Nutr Metab 2001; 14: 18-26.
36. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996; 45: 822-824.
37. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533-1540.
38. Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287: 1706-1709.
39. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk Communities (ARIC) Study. Arterioscler Thromb 1994; 14: 1098-1104.
40. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-256.
41. Soderberg S, Olsson T, Eliasson M, Johnson O, Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 1999; 245: 533-543.
42. Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf.) 1997; 46: 175-181.
43. Halle M, Berg A, Garwers U, Grathwohl D, Knisel W, Keul J. Concurrent reductions of serum leptin and lipids during weight loss in obese men with type II diabetes. Am J Physiol 1999; 277: E277-E282.
44. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-4641.
45. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157: 495-503.
46. Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS. Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 1997; 14: 376-380.
47. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997; 132: 237-243.
48. Asakawa H, Tokunaga K, Kawakami F. Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients. J Diabetes Complications 2001; 15: 57-62.
49. Couillard C, Mauriege P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabelologia 1997; 40: 1178-1184.